Request Sample
Request Methodology
Description
The synthetic Biology Market size is estimated to reach USD 9.32 billion at a CAGR of 26.5% from 2022 to 2028. Synthetic biology is a new interdisciplinary area of the medical field that involves the application of engineering principles in biology. Synthetic biology combines various disciplines within both domains such as genetic engineering, biotechnology, molecular engineering biophysics, computer engineering, electrical engineering and other various branches for the development of artificial biological systems for research engineering and medical applications. The design and building of new biological parts, equipment, and systems, as well as the re-design of existing, natural biological systems for practical purposes, are all examples of synthetic biology. Furthermore, it has various applications in industrial enzymes, vaccines and antibody production, bio-based chemicals as well as synthetic biological life science research. Synthetic biology is an evolutionary segment of medical technology and market is in the developing stage. Market players and researchers are actively participating in R&D activities to develop and introduce the revolutionary technologies. Furthermore, government funding and support for the research fuelling the market growth. Pharmaceutical and biotechnology businesses spend a lot of money on research in order to produce breakthrough compounds that will meet the rising needs of the healthcare industry and fight new ailments. Collaboration and acquisitions are key strategies adopted by the market players to boost their market revenue share in synthetic biology market. For instance, in March 2015, Synpromics Limited, collaborated with iniQure N.V. to develop synthetic promoters with a specific application in the delivery of gene medicines to the liver.
